Original Research

Page 61

Original Research

Efficacy and Safety of Adjunctive Oral Ziprasidone for Acute Treatment of Depression in Patients With Bipolar I Disorder: A Randomized, Double-Blind, Placebo-Controlled Trial

May 3, 2011

Gary S. Sachs, Kathleen S. Ice, Phillip B. Chappell, et al

Original Research

Sudden Deaths in Psychiatric Patients

May 3, 2011

Peter Manu, John M. Kane, Christoph U. Correll

Original Research

Effects of Acute Hydrocortisone Administration on Declarative Memory in Patients With Major Depressive Disorder: A Placebo-Controlled, Double-Blind Crossover Study

April 19, 2011

Kirsten Terfehr, Oliver Tobias Wolf, Nicole Schlosser, et al

Original Research

Efficacy of Antidepressants for Dysthymia: A Meta-Analysis of Placebo-Controlled Randomized Trials

April 15, 2011

Yeciel Levkovitz, Enrico Tedeschini, George I. Papakostas

Original Research

Exploratory Analyses of Efficacy Data From Major Depressive Disorder Trials Submitted to the US Food and Drug Administration in Support of New Drug Applications

April 15, 2011

Ni A. Khin, Yeh-Fong Chen, Yang Yang, et al

Original Research

The Impact of Stimuli on Affect in Persons With Dementia

April 15, 2011

Jiska Cohen-Mansfield, Marcia S. Marx, Khin Thein, et al

Original Research

A Randomized, Double-Blind, Placebo-Controlled, 8-Week Study of Vilazodone, a Serotonergic Agent for the Treatment of Major Depressive Disorder

April 15, 2011

Arif Khan, Andrew J. Cutler, Daniel K. Kajdasz, et al

Original Research

Risk of Arrest in Persons With Schizophrenia and Bipolar Disorder in a Florida Medicaid Program: The Role of Atypical Antipsychotics, Conventional Neuroleptics, and Routine Outpatient Behavioral Health Services

April 15, 2011

Richard A. Van Dorn, Ross Andel, Timothy L. Boaz, et al

Original Research

Bupropion Sustained Release Added to Group Support for Smoking Cessation in Schizophrenia: A New Randomized Trial and a Meta-Analysis

April 5, 2011

Elaine Weiner, M. Patricia Ball, Alison S. Buchholz, et al

Original Research

A Dose Comparison of Olanzapine for the Treatment of Borderline Personality Disorder: A 12-Week Randomized, Double-Blind, Placebo-Controlled Study

April 5, 2011

Mary C. Zanarini, S. Charles Schulz, Holland C. Detke, et al

Original Research

Metabolic Depression: A Chronic Depressive Subtype? Findings From the InCHIANTI Study of Older Persons

April 5, 2011

Nicole Vogelzangs, Aartjan T. F. Beekman, Ingrid G. Boelhouwer, et al

Original Research

Panic as an Independent Risk Factor for Suicide Attempt in Depressive Illness: Findings From the National Epidemiological Survey on Alcohol and Related Conditions (NESARC)

March 22, 2011

Curren Katz, Zimri S. Yaseen, Ramin Mojtabai, et al

Original Research

Assessments of Suicidality in Double-Blind, Placebo-Controlled Trials of Ziprasidone

March 15, 2011

Onur N. Karayal, Susan D. Anway, Evan Batzar, et al

Original Research

Psychological Characteristics of Chronic Depression: A Longitudinal Cohort Study

March 15, 2011

Jenneke E. Wiersma, Patricia van Oppen, Digna J. F. van Schaik, et al

Original Research

The Same or Different? A Phenomenological Comparison of Auditory Verbal Hallucinations in Healthy and Psychotic Individuals

March 15, 2011

Kirstin Daalman, Marco P. M. Boks, Kelly M. J. Diederen, et al

Original Research

An Algorithm-Based Approach to First-Episode Schizophrenia: Response Rates Over 3 Prospective Antipsychotic Trials With a Retrospective Data Analysis

March 8, 2011

Ofer Agid, Tamara Arenovich, Gautam Sajeev, et al

Original Research

Brief Behavioral Therapy for Refractory Insomnia in Residual Depression: An Assessor-Blind, Randomized Controlled Trial

March 8, 2011

Norio Watanabe, Toshi A. Furukawa, Shinji Shimodera, et al

Original Research

Clinical Utility of Early Improvement to Predict Response or Remission in Acute Mania: Focus on Olanzapine and Risperidone

March 8, 2011

David E. Kemp, Ellyn Johnson, Wei V. Wang, et al

Original Research

Temporal Relationships Between Overweight and Obesity and DSM-IV Substance Use, Mood, and Anxiety Disorders: Results From a Prospective Study, the National Epidemiologic Survey on Alcohol and Related Conditions

March 8, 2011

Roger P. Pickering, RisÃ« B. Goldstein, Deborah S. Hasin, et al

Original Research

A Double-Blind Placebo-Controlled Trial of Lamotrigine as an Antidepressant Augmentation Agent in Treatment-Refractory Unipolar Depression

February 22, 2011

James G. Barbee, Thomas R. Thompson, Nowal J. Jamhour, et al

Original Research

Eszopiclone for PTSD & Insomnia Treatment

February 22, 2011

Read the full study on whether pharmacotherapy with eszopiclone improved short-term in PTSD severity and associated sleep disturbance

Mark H. Pollack, Elizabeth A. Hoge, John J. Worthington, et al

Original Research

Quality of and Patient Satisfaction With Primary Health Care for Anxiety Disorders

February 22, 2011

Murray B. Stein, Peter P. Roy-Byrne, Michelle G. Craske, et al

Original Research

A Randomized Placebo-Controlled Trial of Asenapine for the Prevention of Relapse of Schizophrenia After Long-Term Treatment

February 22, 2011

John M. Kane, Mary Mackle, Linda Snow-Adami, et al

Original Research

Why Do Some Patients With Schizophrenia Want to Be Engaged in Medical Decision Making and Others Do Not?

February 22, 2011

Johannes Hamann, Rosmarie Mendel, Sarah Reiter, et al

« 1 … 59 60 61 62 63 … 159 »

Original Research

Efficacy and Safety of Adjunctive Oral Ziprasidone for Acute Treatment of Depression in Patients With Bipolar I Disorder: A Randomized, Double-Blind, Placebo-Controlled Trial

Sudden Deaths in Psychiatric Patients

Effects of Acute Hydrocortisone Administration on Declarative Memory in Patients With Major Depressive Disorder: A Placebo-Controlled, Double-Blind Crossover Study

Efficacy of Antidepressants for Dysthymia: A Meta-Analysis of Placebo-Controlled Randomized Trials

Exploratory Analyses of Efficacy Data From Major Depressive Disorder Trials Submitted to the US Food and Drug Administration in Support of New Drug Applications

The Impact of Stimuli on Affect in Persons With Dementia

A Randomized, Double-Blind, Placebo-Controlled, 8-Week Study of Vilazodone, a Serotonergic Agent for the Treatment of Major Depressive Disorder

Risk of Arrest in Persons With Schizophrenia and Bipolar Disorder in a Florida Medicaid Program: The Role of Atypical Antipsychotics, Conventional Neuroleptics, and Routine Outpatient Behavioral Health Services

Bupropion Sustained Release Added to Group Support for Smoking Cessation in Schizophrenia: A New Randomized Trial and a Meta-Analysis

A Dose Comparison of Olanzapine for the Treatment of Borderline Personality Disorder: A 12-Week Randomized, Double-Blind, Placebo-Controlled Study

Metabolic Depression: A Chronic Depressive Subtype? Findings From the InCHIANTI Study of Older Persons

Panic as an Independent Risk Factor for Suicide Attempt in Depressive Illness: Findings From the National Epidemiological Survey on Alcohol and Related Conditions (NESARC)

Assessments of Suicidality in Double-Blind, Placebo-Controlled Trials of Ziprasidone

Psychological Characteristics of Chronic Depression: A Longitudinal Cohort Study

The Same or Different? A Phenomenological Comparison of Auditory Verbal Hallucinations in Healthy and Psychotic Individuals

An Algorithm-Based Approach to First-Episode Schizophrenia: Response Rates Over 3 Prospective Antipsychotic Trials With a Retrospective Data Analysis

Brief Behavioral Therapy for Refractory Insomnia in Residual Depression: An Assessor-Blind, Randomized Controlled Trial

Clinical Utility of Early Improvement to Predict Response or Remission in Acute Mania: Focus on Olanzapine and Risperidone

Temporal Relationships Between Overweight and Obesity and DSM-IV Substance Use, Mood, and Anxiety Disorders: Results From a Prospective Study, the National Epidemiologic Survey on Alcohol and Related Conditions

A Double-Blind Placebo-Controlled Trial of Lamotrigine as an Antidepressant Augmentation Agent in Treatment-Refractory Unipolar Depression

Eszopiclone for PTSD & Insomnia Treatment

Quality of and Patient Satisfaction With Primary Health Care for Anxiety Disorders

A Randomized Placebo-Controlled Trial of Asenapine for the Prevention of Relapse of Schizophrenia After Long-Term Treatment

Why Do Some Patients With Schizophrenia Want to Be Engaged in Medical Decision Making and Others Do Not?

ELSEWHERE:

FOLLOW US:

Original Research

Efficacy and Safety of Adjunctive Oral Ziprasidone for Acute Treatment of Depression in Patients With Bipolar I Disorder: A Randomized, Double-Blind, Placebo-Controlled Trial

Sudden Deaths in Psychiatric Patients

Effects of Acute Hydrocortisone Administration on Declarative Memory in Patients With Major Depressive Disorder: A Placebo-Controlled, Double-Blind Crossover Study

Efficacy of Antidepressants for Dysthymia: A Meta-Analysis of Placebo-Controlled Randomized Trials

Exploratory Analyses of Efficacy Data From Major Depressive Disorder Trials Submitted to the US Food and Drug Administration in Support of New Drug Applications

The Impact of Stimuli on Affect in Persons With Dementia

A Randomized, Double-Blind, Placebo-Controlled, 8-Week Study of Vilazodone, a Serotonergic Agent for the Treatment of Major Depressive Disorder

Risk of Arrest in Persons With Schizophrenia and Bipolar Disorder in a Florida Medicaid Program: The Role of Atypical Antipsychotics, Conventional Neuroleptics, and Routine Outpatient Behavioral Health Services

Bupropion Sustained Release Added to Group Support for Smoking Cessation in Schizophrenia: A New Randomized Trial and a Meta-Analysis

A Dose Comparison of Olanzapine for the Treatment of Borderline Personality Disorder: A 12-Week Randomized, Double-Blind, Placebo-Controlled Study

Metabolic Depression: A Chronic Depressive Subtype? Findings From the InCHIANTI Study of Older Persons

Panic as an Independent Risk Factor for Suicide Attempt in Depressive Illness: Findings From the National Epidemiological Survey on Alcohol and Related Conditions (NESARC)

Assessments of Suicidality in Double-Blind, Placebo-Controlled Trials of Ziprasidone

Psychological Characteristics of Chronic Depression: A Longitudinal Cohort Study

The Same or Different? A Phenomenological Comparison of Auditory Verbal Hallucinations in Healthy and Psychotic Individuals

An Algorithm-Based Approach to First-Episode Schizophrenia: Response Rates Over 3 Prospective Antipsychotic Trials With a Retrospective Data Analysis

Brief Behavioral Therapy for Refractory Insomnia in Residual Depression: An Assessor-Blind, Randomized Controlled Trial

Clinical Utility of Early Improvement to Predict Response or Remission in Acute Mania: Focus on Olanzapine and Risperidone

Temporal Relationships Between Overweight and Obesity and DSM-IV Substance Use, Mood, and Anxiety Disorders: Results From a Prospective Study, the National Epidemiologic Survey on Alcohol and Related Conditions

A Double-Blind Placebo-Controlled Trial of Lamotrigine as an Antidepressant Augmentation Agent in Treatment-Refractory Unipolar Depression

Eszopiclone for PTSD & Insomnia Treatment

Quality of and Patient Satisfaction With Primary Health Care for Anxiety Disorders

A Randomized Placebo-Controlled Trial of Asenapine for the Prevention of Relapse of Schizophrenia After Long-Term Treatment

Why Do Some Patients With Schizophrenia Want to Be Engaged in Medical Decision Making and Others Do Not?

Celebrating85 Years

Subscribe to readmore articles

Celebrating
85 Years

Subscribe to read
more articles